Do investors appreciate this is a Phase 2a clinical trial? IHL’s unique IHL-42X formula is building on existing science. One study I read reported a 30% reduction in the apnea-hypopnea index using Dronabinol versus the placebo.
Or to put it another way, the existing studies have already demonstrated efficacy in the treatment of OSA using Dronabinol. The difference is no one has completed a study in Australia and historically the use of medicinal cannabis was not a legal pharmaceutical option.
The successful psoriasis study by Botanix resulted in their share price going to $200 million and that was only a Phase 1b trial,this is Phase 2a.
- Forums
- ASX - By Stock
- IHL
- Ann: Commencement of Phase 2a Sleep Apnoea Clinical Trial
Ann: Commencement of Phase 2a Sleep Apnoea Clinical Trial, page-13
-
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin